Good FY24 numbers but challenging FY25 outlook.
FY25 Guidance:
1. Revenue growth of +10% to +14% to A$214-222m (-7% consensus at A$234m), with MP1 focus on accelerating growth through the next 3 years
2. EBITDA growth of +0% to +14% to A$57-65m (-22% consensus at A$78m) with Jun-24 EBITDA being $4.5m, implying $54mnannualised.
3. Capex of $27-30mn (consensus at $35mn).
Happy to hold owing to my $4.63 average. Enough fat in the current holding for the vicissitude of the next 3 years. I will be buying more but it might be a bit premature to do it today. This guidance reflects continuation of profitable efficient growth, while reinvesting in the business to drive long-term growth. Definitely reigning in short term expectations a bit. Bad for those expecting instant re-rate.
Good FY24 numbers but challenging FY25 outlook.FY25 Guidance: 1....
-
- There are more pages in this discussion • 67 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MP1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$7.31 |
Change
0.270(3.84%) |
Mkt cap ! $1.170B | |||
| Open | High | Low | Value | Volume |
| $7.16 | $7.37 | $7.13 | $9.380M | 1.287M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1847 | $7.31 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $7.35 | 14004 | 2 |
View Market Depth
| Last trade - 16.10pm 26/09/2024 (20 minute delay) ? |
| MP1 (ASX) Chart |